List of bibliographic references indexed by screening
Number of relevant bibliographic references: 17.
| Ident. | Authors (with country if any) | Title |
|---|
| 000038 (2021) |
María Antonela Zígolo [Argentine] ; Matías Rivero Goytia [Argentine] ; Hugo Ramiro Poma [Argentine] ; Ver Nica Beatriz Rajal [Singapour] ; Ver Nica Patricia Irazusta [Argentine] | Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools. |
| 000127 (2021) |
Thirumal Kumar D [Inde] ; Nishaat Shaikh [Inde] ; Udhaya Kumar S [Inde] ; George Priya Doss C [Inde] ; Hatem Zayed [Qatar] | Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2. |
| 000326 (2021) |
C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde] | Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. |
| 000333 (2021) |
Arif Ali [Inde] ; Nasim Sepay [Inde] ; Mohd Afzal [Arabie saoudite] ; Nayim Sepay [Inde] ; Abdullah Alarifi [Arabie saoudite] ; M. Shahid [Inde] ; Musheer Ahmad [Inde] | Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19. |
| 000466 (2021) |
Iram Iqbal Hejazi [Inde] ; Md Amjad Beg [Inde] ; Md Ali Imam [Inde] ; Fareeda Athar [Inde] ; Asimul Islam [Inde] | Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease. |
| 000590 (2021) |
Maryam Hosseini [États-Unis] ; Wanqiu Chen [États-Unis] ; Daliao Xiao [États-Unis] ; Charles Wang [États-Unis] | Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs. |
| 000718 (2021) |
Moamen S. Refat [Arabie saoudite] ; Anas A. Sedayo [Arabie saoudite] ; Ali Sayqal [Arabie saoudite] ; Arwa Alharbi [Arabie saoudite] ; Hanadi A. Katouah [Arabie saoudite] ; Hana M. Abumelha [Arabie saoudite] ; Seraj Alzahrani [Arabie saoudite] ; Fatmah Alkhatib [Arabie saoudite] ; Ismail Althagafi [Arabie saoudite] ; Nashwa El-Metwaly [Arabie saoudite, Égypte] | Aurintricarboxylic acid and its metal ion complexes in comparative virtual screening versus Lopinavir and Hydroxychloroquine in fighting COVID-19 pandemic: Synthesis and characterization. |
| 000772 (2021) |
Juhi Saraswat [Inde] ; Prashant Singh [Inde] ; Rajan Patel [Inde] | A computational approach for the screening of potential antiviral compounds against SARS-CoV-2 protease: Ionic liquid vs herbal and natural compounds. |
| 000985 (2020) |
Emanuelle Machado Marinho [Brésil] ; João Batista De Andrade Neto [Brésil] ; Jacilene Silva [Brésil] ; Cecília Rocha Da Silva [Brésil] ; Bruno Coelho Cavalcanti [Brésil] ; Emmanuel Silva Marinho [Brésil] ; Hélio Vitoriano Nobre Júnior [Brésil] | Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease. |
| 000A93 (2020) |
A S Achutha [Inde] ; V L Pushpa [Inde] ; Surendran Suchitra [Inde] | Theoretical Insights into the Anti-SARS-CoV-2 Activity of Chloroquine and Its Analogs and In Silico Screening of Main Protease Inhibitors. |
| 000C27 (2020) |
Mallikarjuna Nimgampalle [Inde] ; Vasudharani Devanathan [Inde] ; Ambrish Saxena [Inde] | Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets. |
| 000C28 (2020) |
Praveen Kumar Tripathi [Inde] ; Saurabh Upadhyay [Inde] ; Manju Singh [Inde] ; Siva Raghavendhar [Inde] ; Mohit Bhardwaj [Inde] ; Pradeep Sharma [Inde] ; Ashok Kumar Patel [Inde] | Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2. |
| 000C51 (2020) |
Cristina Adriana Dehelean [Roumanie] ; Voichita Lazureanu [Roumanie] ; Dorina Coricovac [Roumanie] ; Marius Mioc [Roumanie] ; Roxana Oancea [Roumanie] ; Iasmina Marcovici [Roumanie] ; Iulia Pinzaru [Roumanie] ; Codruta Soica [Roumanie] ; Aristidis M. Tsatsakis [Grèce] ; Octavian Cretu [Roumanie] | SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening. |
| 001074 (2020) |
Adib Ghaleb [Maroc] ; Adnane Aouidate [Maroc] ; Hicham Ben El Ayouchia [Maroc] ; Mohammed Aarjane [Maroc] ; Hafid Anane [Maroc] ; Salah-Eddine Stiriba [Maroc, Espagne] | In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening. |
| 001113 (2020) |
Zhe Li [République populaire de Chine] ; Xin Li [République populaire de Chine] ; Yi-You Huang [République populaire de Chine] ; Yaoxing Wu [République populaire de Chine] ; Runduo Liu [République populaire de Chine] ; Lingli Zhou [République populaire de Chine] ; Yuxi Lin [République populaire de Chine] ; Deyan Wu [République populaire de Chine] ; Lei Zhang [République populaire de Chine] ; Hao Liu [République populaire de Chine] ; Ximing Xu [République populaire de Chine] ; Kunqian Yu [République populaire de Chine] ; Yuxia Zhang [République populaire de Chine] ; Jun Cui [République populaire de Chine] ; Chang-Guo Zhan [République populaire de Chine, États-Unis] ; Xin Wang [République populaire de Chine] ; Hai-Bin Luo [République populaire de Chine] | Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. |
| 001420 (2020) |
Shuofeng Yuan ; Jasper F W. Chan [Hong Kong] ; Kenn K H. Chik ; Chris C Y. Chan ; Jessica O L. Tsang ; Ronghui Liang ; Jianli Cao ; Kaiming Tang ; Lin-Lei Chen ; Kun Wen [République populaire de Chine] ; Jian-Piao Cai ; Zi-Wei Ye ; Gang Lu [République populaire de Chine] ; Hin Chu ; Dong-Yan Jin ; Kwok-Yung Yuen [Hong Kong] | Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. |
| 001525 (2020) |
Bruno Silva Andrade [Brésil] ; Preetam Ghosh [États-Unis] ; Debmalya Barh [Inde] ; Sandeep Tiwari [Brésil] ; Raner José Santana Silva [Brésil] ; Wagner Rodrigues De Assis Soares [Brésil] ; Tarcisio Silva Melo [Brésil] ; Andria Santos Freitas [Brésil] ; Patrícia González-Grande [Brésil] ; Lucas Sousa Palmeira [Brésil] ; Luiz Carlos Junior Alcantara [Brésil] ; Marta Giovanetti [Brésil] ; Arist Teles G Es-Neto [Brésil] ; Vasco Ariston De Carvalho Azevedo [Brésil] | Computational screening for potential drug candidates against the SARS-CoV-2 main protease. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "screening"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "screening" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= screening
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
